Physician profile
Lane Kocovsky
NPI 1912579996
$1,210.67
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $238 · 2022: $870 · 2023: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $102.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $493.43 | 2021-2023 | Ozempic, Rybelsus |
| Daiichi Sankyo INC. | $362.85 | 2021-2023 | Injectafer |
| Medtronic, INC. | $61.75 | 2021-2023 | Guardian Connect |
| Glaxosmithkline, LLC. | $59.19 | 2021-2023 | Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $51.24 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.79 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $27.77 | 2022 | |
| Amarin Pharma, INC. | $27.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.60 | 2022 | |
| Althera Pharmaceuticals LLC | $14.93 | 2022 | |
| Seqirus USA INC | $14.55 | 2021 | |
| Horizon Therapeutics Plc | $14.29 | 2022 | |
| Abbvie INC. | $13.61 | 2022 | |
| Pfizer INC. | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lane Kocovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.